Overview
Parallel Scientific Advice: FDA-EMA Parallel Scientific Advice (PSA) Program
Register here
Event Agenda
DATE: Wednesday, 20 July 2022
TIME: 6:00 – 6:05 PM Welcome and Announcements
6:05 – 7:05 PM Program Presentation
7:05 – 7:30 PM Q & A
LOCATION: This is an ONLINE event on zoom virtual platform
Program Details
The Parallel Scientific Advice (PSA) Program is a program shared by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) that provides a mechanism for experts from both the agencies to concurrently engage in scientific discourse with sponsors on key issues during the development phase of new medicinal products.
Speaker Biography
Valmik Doshi, MS is a US Regulatory Lead for Neurocrine’s clinical stage schizophrenia disease compounds. In his role, he lead as well participate in the development and execution of US and Global regulatory strategies in conjunction with Global Regulatory Lead (GRL) and cross-functional team members. Prior to joining Neurocrine, he spent ~7+ years in regulatory affairs at Alkermes, Takeda, Infinity Pharmaceuticals and worked in Central Nervous System (CNS) and Oncology therapeutic areas. He has a BS in Pharmacy and MS in Drug Regulatory Affairs and Health Policies from Massachusetts College of Pharmacy and Health Sciences, Boston.
Contact
Pricing – Online – Registration (June 20, 2022 – July 19, 2022)
| Registrant Type | Price |
| Member | $10.00 |
| Lifetime | $10.00 |
| Non-Member | $15.00 |
|
OCRA Member
|
$10.00
|
Cancellation Policy
There will be no refunds for cancellations.
Recent Comments